申请人:Slama Schwok Anny
公开号:US20140163107A1
公开(公告)日:2014-06-12
A pharmaceutical composition for treating viral infections by an influenza type A virus, includes a compound capable of acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of influenza type A viruses, and capable of binding to the viral-RNA-binding domain on the nucleoprotein. A pharmaceutical composition for treating viral infections by an orthomyxovirus, includes a compound capable of acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of orthomyxoviruses, and capable of binding to the viral-RNA-binding domain on the nucleoprotein of the viruses. A compound acting as an inhibitor of the binding of the viral RNA to the nucleoprotein of influenza type A viruses, and binding to the viral-RNA-binding domain on the nucleoprotein of influenza type A viruses and a method for identifying such a compound having these properties are also described.
一种治疗流感A型病毒引起的病毒感染的药物组合物,包括一种能够作为流感A型病毒的核蛋白与病毒RNA结合的抑制剂的化合物,并且能够结合到核蛋白上的病毒-RNA结合结构域。一种治疗正黏病毒引起的病毒感染的药物组合物,包括一种能够作为正黏病毒的核蛋白与病毒RNA结合的抑制剂的化合物,并且能够结合到病毒的核蛋白上的病毒-RNA结合结构域。还描述了一种作为流感A型病毒的核蛋白与病毒RNA结合的抑制剂,并且能够结合到流感A型病毒的核蛋白上的病毒-RNA结合结构域的化合物,以及识别具有这些特性的化合物的方法。